| Mark Thomas Hepworth, | |
|
1200 1st Ave E Ste 1, Spencer, IA 51301-4330 | |
| (712) 264-6228 | |
| Not Available |
| Full Name | Mark Thomas Hepworth |
|---|---|
| Gender | Male |
| Speciality | Nurse Practitioner |
| Experience | 4 Years |
| Location | 1200 1st Ave E Ste 1, Spencer, Iowa |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1487232302 | NPI | - | NPPES |
| G162956 | Other | IA | ARNP LICENSE NUMBER |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 363LP0808X | Nurse Practitioner - Psychiatric/mental Health | G162956 (Iowa) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Spencer Municipal Hospital | Spencer, IA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Spencer Municipal Hospital | 4183533060 | 83 |
News Archive
Revealing surprising answers to a long-standing enigma about the brain target of the anti-obesity hormone leptin, neuroscientists at Tufts University School of Medicine have used CRISPR genome editing to identify a neural circuit in the hypothalamus as the primary mechanism in mediating leptin's anti-obesity and anti-diabetes effects and have identified two distinct mechanisms underlying leptin's inhibition of appetite.
Damage to heart muscle from insufficient blood supply during cardiac arrest and reperfusion injury after blood flow is restored can be reduced by nearly 90 percent if selenide, a form of the essential nutrient selenium, is administered intravenously in the wake of the attack, according to a new preclinical study by researchers at Fred Hutchinson Cancer Research Center.
QRxPharma Limited announced today execution of its License and Option Agreement with Actavis, Inc. which finalised the legal terms and conditions to commercialise MoxDuo IR in the US acute pain marketplace. The LOA completion follows a 20 December 2011 signing of a binding Letter of Intent secured by a US$6 million non-refundable upfront signing fee to QRxPharma.
Many researchers are attempting to identify risk factors for severe or critical COVID-19. A recent paper in the journal Medical Hypotheses in September 2020 suggests that macrophage class activation is one of the factors that determine the clinical phenotype of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection.
› Verified 2 days ago
| Entity Name | Spencer Municipal Hospital |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1396732186 PECOS PAC ID: 4183533060 Enrollment ID: O20040128000325 |
News Archive
Revealing surprising answers to a long-standing enigma about the brain target of the anti-obesity hormone leptin, neuroscientists at Tufts University School of Medicine have used CRISPR genome editing to identify a neural circuit in the hypothalamus as the primary mechanism in mediating leptin's anti-obesity and anti-diabetes effects and have identified two distinct mechanisms underlying leptin's inhibition of appetite.
Damage to heart muscle from insufficient blood supply during cardiac arrest and reperfusion injury after blood flow is restored can be reduced by nearly 90 percent if selenide, a form of the essential nutrient selenium, is administered intravenously in the wake of the attack, according to a new preclinical study by researchers at Fred Hutchinson Cancer Research Center.
QRxPharma Limited announced today execution of its License and Option Agreement with Actavis, Inc. which finalised the legal terms and conditions to commercialise MoxDuo IR in the US acute pain marketplace. The LOA completion follows a 20 December 2011 signing of a binding Letter of Intent secured by a US$6 million non-refundable upfront signing fee to QRxPharma.
Many researchers are attempting to identify risk factors for severe or critical COVID-19. A recent paper in the journal Medical Hypotheses in September 2020 suggests that macrophage class activation is one of the factors that determine the clinical phenotype of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Mark Thomas Hepworth, 1200 1st Ave E Ste 1, Spencer, IA 51301-4330 Ph: (712) 264-6228 | Mark Thomas Hepworth, 1200 1st Ave E Ste 1, Spencer, IA 51301-4330 Ph: (712) 264-6228 |
News Archive
Revealing surprising answers to a long-standing enigma about the brain target of the anti-obesity hormone leptin, neuroscientists at Tufts University School of Medicine have used CRISPR genome editing to identify a neural circuit in the hypothalamus as the primary mechanism in mediating leptin's anti-obesity and anti-diabetes effects and have identified two distinct mechanisms underlying leptin's inhibition of appetite.
Damage to heart muscle from insufficient blood supply during cardiac arrest and reperfusion injury after blood flow is restored can be reduced by nearly 90 percent if selenide, a form of the essential nutrient selenium, is administered intravenously in the wake of the attack, according to a new preclinical study by researchers at Fred Hutchinson Cancer Research Center.
QRxPharma Limited announced today execution of its License and Option Agreement with Actavis, Inc. which finalised the legal terms and conditions to commercialise MoxDuo IR in the US acute pain marketplace. The LOA completion follows a 20 December 2011 signing of a binding Letter of Intent secured by a US$6 million non-refundable upfront signing fee to QRxPharma.
Many researchers are attempting to identify risk factors for severe or critical COVID-19. A recent paper in the journal Medical Hypotheses in September 2020 suggests that macrophage class activation is one of the factors that determine the clinical phenotype of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection.
› Verified 2 days ago
Kathi Kae Heckert, CNP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 116 E 11th St, Ste 101, Spencer, IA 51301 Phone: 712-264-3500 Fax: 712-264-3535 | |
Sara Casey, ARNP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 116 E 11th St, Spencer, IA 51301 Phone: 712-264-3500 | |
Kimberly Goslinga, ARNP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 201 E 11th St, Spencer, IA 51301 Phone: 800-242-5101 | |
Jill A. Hustedt, ARNP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 337 11th St Sw, Spencer, IA 51301 Phone: 712-792-7500 Fax: 712-792-7510 | |
Leisha Fischer, ARNP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 116 East 7th Street, Suite 2, Spencer, IA 51301 Phone: 712-580-6592 Fax: 712-580-6593 | |
Kathryn S Nelson, ARNP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 337 11th St Sw, Spencer, IA 51301 Phone: 712-580-4570 Fax: 712-580-4573 | |
Ms. Kimberly Whisenant, NP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 116 E 11th St Ste 101, Spencer, IA 51301 Phone: 712-264-3500 Fax: 712-264-3525 |